Arterial, Venous, and Capillary Blood Ammonia

Overview

About this study

The purpose of this study is to compare Arterial, Venous, and Capillary Blood Ammonia.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Subject is ≥18 years of age
  • Subject with:
    • EITHER
      an arterial blood sample ordered as part of their standard medical care; examples include:
      • An individual without chronic liver disease who is undergoing arterial blood sampling as part of their standard of care in the outpatient arena (e.g., for evaluation of acid-base abnormalities or pulmonary disease)
      • An individual with chronic liver disease who is undergoing arterial blood sampling as part of their standard of care in the outpatient arena (e.g., as part of a liver transplantation work-up)
    • OR
      an indwelling arterial catheter (e.g., suitable for obtaining an arterial blood sample); examples include:
      • An individual undergoing surgery in which an arterial catheter is placed as part of their standard of care
      • An individual in the intensive care unit in which an arterial catheter is placed as part of their standard of care
  • Subject is able to provide a venous blood sample at the time of their arterial blood sample collection; examples of venous blood locations sampled include:
    • Peripheral (via standard phlebotomy from an upper extremity vein)
    • Central (via a peripherally inserted central catheter (PICC) or via central venous catheter (CVC))
  • Subject is able to provide two capillary blood samples (via two finger pricks) at the time of their arterial blood sample collection
  • Subject (or their designated medical decision maker) provides informed consent for participation in this study

Exclusion Criteria:

  • Subject is a member of a vulnerable group, including individuals who may be vulnerable to coercion or undue influence, such as prisoners
  • Subject has a condition that, in the opinion of one of the Study Team members, produces unusual health risk to the subject by their participation

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 06/19/2024. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Leslie Thomas, M.D.

Contact us for the latest status

Contact information:

Samantha Poletti R.N.

(480) 342-2906

poletti.samantha@mayo.edu

More information

Publications

Publications are currently not available